Idenix Pharmaceuticals (IDIX)

Add to Watchlists Create an Alert
4.31 +0.12  +2.86%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Idenix Pharmaceuticals Cash and ST Investments:

205.30M for March 31, 2013
View Full Chart

Idenix Pharmaceuticals Cash and ST Investments Chart

    Idenix Pharmaceuticals Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 205.30M
    Dec. 31, 2012 230.83M
    Sept. 30, 2012 251.87M
    June 30, 2012 79.31M
    March 31, 2012 105.26M
    Dec. 31, 2011 118.27M
    Sept. 30, 2011 64.69M
    June 30, 2011 78.35M
    March 31, 2011 31.41M
    Dec. 31, 2010 46.12M
    Sept. 30, 2010 37.02M
    June 30, 2010 51.01M
    March 31, 2010 32.34M
    Dec. 31, 2009 46.52M
    Sept. 30, 2009 59.50M
    June 30, 2009 50.13M
    March 31, 2009 62.57M
    Dec. 31, 2008 42.93M
    Sept. 30, 2008 52.63M
       
    June 30, 2008 70.33M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    IDIX Cash and ST Investments Benchmarks

    Companies
    Achillion Pharmaceuticals 144.99M
    Vertex Pharmaceuticals 1.239B
    Peregrine Pharmaceuticals 26.26M

    IDIX Cash and ST Investments Rankings

    Overall 81st percentile
    1399 of 7600
    Sector 80th percentile
    126 of 653 in Healthcare
    Industry 84th percentile
    36 of 238 in Biotechnology

    IDIX Cash and ST Investments Range, Past 5 Years

    Minimum 31.41M Mar 2011
    Maximum 251.87M Sep 2012
    Average 85.82M